Medullary thyroid carcinoma and multiple endocrine neoplasia type 2

被引:0
|
作者
Hiroshi Takami
机构
[1] Teikyo University School of Medicine,Department of Surgery
来源
Endocrine Pathology | 2003年 / 14卷
关键词
Calcitonin; medullary thyroid carcinoma; multiple endocrine neoplasia; protooncogene;
D O I
暂无
中图分类号
学科分类号
摘要
Medullary thyroid carcinoma (MTC) occurs as both a sporadic and an inherited disease. MTC is a consistent feature of multiple endocrine neoplasia (MEN) 2A, MEN 2B, and familial non-MEN MTC (FMTC). Plasma calcitonin is a sensitive and specific marker for the presence of MTC. Genetic testing can identify mutant gene carriers, and prophylactic total thyroidectomy should be carried out in patients with the mutant gene. The outcome of MTC is progressively worse in FMTC, MEN 2A, sporadic MTC, and MEN 2B, and MEN 2B has been found to have the worst prognosis. There is a significant genotype-phenotype correlation, which allows a more sensitive individualized approach to the timing and extent of prophylactic thyroidectomy.
引用
收藏
页码:123 / 131
页数:8
相关论文
共 50 条
  • [41] Multiple endocrine neoplasia type 2
    Niccoli-Sire, P.
    Conte-Devolx, B.
    ANNALES D ENDOCRINOLOGIE, 2007, 68 (05) : 317 - 324
  • [42] Multiple Endocrine Neoplasia Type 2
    Lodish, Maya
    ENDOCRINE TUMOR SYNDROMES AND THEIR GENETICS, 2013, 41 : 16 - 29
  • [43] Medullary thyroid carcinoma identified within the first year of life in children with hereditary multiple endocrine neoplasia type 2A (codon 634) and 2B
    Zenaty, D.
    Aigrain, Y.
    Peuchmaur, M.
    Philippe-Chomette, P.
    Baumann, C.
    Cornelis, F.
    Hugot, J. P.
    Chevenne, D.
    Barbu, V.
    Guillausseau, P. J.
    Schlumberger, M.
    Carel, J. C.
    Travagli, J. P.
    Leger, J.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2009, 160 (05) : 807 - 813
  • [44] Multiple endocrine neoplasia type 2
    Mariola Peczkowska
    Andrzej Januszewicz
    Familial Cancer, 2005, 4 : 25 - 36
  • [45] Multiple endocrine neoplasia type 2
    Gertner M.E.
    Kebebew E.
    Current Treatment Options in Oncology, 2004, 5 (4) : 315 - 325
  • [46] Prophylactic thyroidectomy in multiple endocrine neoplasia type 2
    Raue, Friedhelm
    Frank-Raue, Karin
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2010, 5 (06) : 867 - 874
  • [47] What is New in Multiple Endocrine Neoplasia Type 2?
    Cakir, Mehtap
    ENDOCRINOLOGY RESEARCH AND PRACTICE, 2025, 29 (01): : 59 - 68
  • [48] Iodine 123 metaiodobenzylguanidine radio-guided navigation surgery for recurrent medullary thyroid carcinoma in a girl with multiple endocrine neoplasia type 2B
    Shimotake, T
    Tsuda, T
    Aoi, S
    Fumino, S
    Iwai, N
    JOURNAL OF PEDIATRIC SURGERY, 2005, 40 (10) : 1643 - 1646
  • [49] IMMUNOSTAINS FOR COLLAGEN TYPE-IV DISCRIMINATE BETWEEN C-CELL HYPERPLASIA AND MICROSCOPIC MEDULLARY CARCINOMA IN MULTIPLE ENDOCRINE NEOPLASIA, TYPE 2A
    MCDERMOTT, MB
    SWANSON, PE
    WICK, MR
    HUMAN PATHOLOGY, 1995, 26 (12) : 1308 - 1312
  • [50] Role of RET codonic mutations in the surgical management of medullary thyroid carcinoma in pediatric age multiple endocrine neoplasm type 2 syndromes
    Spinelli, Claudio
    Di Giacomo, Martina
    Costanzo, Sara
    Elisei, Rossella
    Miccoli, Paolo
    JOURNAL OF PEDIATRIC SURGERY, 2010, 45 (08) : 1610 - 1616